Chaouat G, Voisin G A, Escalier D, Robert P
Clin Exp Immunol. 1979 Jan;35(1):13-24.
Humoral and cellular immune agents of a maternal reaction were investigated during pregnancy. Fluorescence studies performed on mouse placentae at 14 days detected maternal immunoglobulins of mainly IgG1 but also IgG2 subclasses. These immunoglobulins, after acid elution, can rebind the placenta and the thymocytes of the relevant paternal strain in case of allogeneic pregnancies, demonstrating an antibody activity towards both placenta specific and paternal strain antigens. They can specifically enhance a paternal strain tumour allograft on a maternal strain recipient. Spleen cells from an allogeneically pregnant mother can reduce or promote paternal strain tumour allograft on a maternal strain recipient. The aggressive effect is shown with small doses of transferred cells, whereas large doses promote enhancement. The suppression of the cytotoxic response of the recipient was ascribed to T cells by use of anti-theta plus complement. Thus, both the rejection reaction (immune cytotoxic cells) and the facilitation reaction (enhancing antibodies and suppressor cells) were demonstrated during pregnancy.
在孕期对母体反应的体液和细胞免疫因子进行了研究。在第14天对小鼠胎盘进行的荧光研究检测到主要为IgG1但也有IgG2亚类的母体免疫球蛋白。在同种异体妊娠的情况下,这些免疫球蛋白经酸洗脱后,能重新结合相关父本品系的胎盘和胸腺细胞,表明其对胎盘特异性抗原和父本品系抗原均具有抗体活性。它们能特异性增强母本品系受体上父本品系肿瘤的同种异体移植。同种异体妊娠母亲的脾细胞可减少或促进母本品系受体上父本品系肿瘤的同种异体移植。小剂量转移细胞显示出侵袭性作用,而大剂量则促进增强作用。通过使用抗θ加补体,将受体细胞毒性反应的抑制归因于T细胞。因此,在孕期既证明了排斥反应(免疫细胞毒性细胞)又证明了促进反应(增强抗体和抑制细胞)。